Reports

Research Resources' Weekly/Friday Newsletter, the R2eport: 

 

R2eport 11/09/18R2eport 11/02/18R2eport 10/26/18R2eport 10/19/18R2eport 10/12/18R2eport 10/05/18R2eport 09/28/18R2eport 09/21/18R2eport 09/14/18R2eport 09/07/18R2eport 08/31/18R2eport 08/24/18R2eport 08/17/18R2eport 08/10/18R2eport 08/03/18R2eport 07/27/18R2eport 07/20/18R2eport 07/13/18R2eport 07/06/18R2eport 06/29/18R2eport 06/22/18;  R2eport 06/15/18R2eport 06/08/18R2eport 06/01/18R2eport 05/25/18R2eport 05/18/18R2eport 05/11/18R2eport 05/04/18R2eport 04/27/18R2eport 04/20/18R2eport 04/13/18R2eport 04/06/18R2eport 03/30/18R2eport 03/23/18R2eport 03/16/18R2eport 03/09/18R2eport 03/02/18R2eport 02/23/18R2eport 02/16/18R2eport 02/09/18R2eport 02/02/18R2eport 01/26/18R2eport 01/19/18R2eport 01/12/18R2eport 01/05/18R2eport 12/29/17 [distributed a day early, due to the holiday]; R2eport 12/22/17R2eport 12/15/17R2eport 12/08/17R2eport 12/01/17; due to the Thanksgiving Holiday, R2 did not publish a newsletter on 11/24/17; R2eport 11/17/17R2eport 11/10/17R2eport 11/03/17R2eport 10/27/17R2eoprt 10/20/17R2eport 10/13/17R2eport 10/06/17R2eport 09/29/17R2eport 09/22/17R2eport 09/15/17R2eport 09/08/17R2eport 09/01/17R2eport 08/25/17R2eport 08/18/17R2eport 08/11/17R2eport 08/04/17R2eport 07/28/17R2eport 07/21/17R2eport 07/14/17R2eport 07/07/17R2eport 06/30/17R2eport 06/23/17R2eport 06/16/17R2eport 06/09/17R2eport 06/02/17R2eport 05/26/17R2eport 05/19/17R2eport 05/12/17R2eport 05/05/17R2eport 04/28/17R2eport 04/21/17R2eport 04/14/17R2eport 04/07/17R2eport 03/31/17R2eport 03/24/17R2eport 03/17/17R2eport 03/10/17R2eport 03/03/17R2eport 02/24/17R2eport 02/17/17R2eport 02/10/17R2eport 02/03/17R2eport 01/27/17R2eport 01/20/17R2eport 01/13/17R2eport 01/06/17R2eport 12/30/16R2eport 12/23/16R2eport 12/16/16R2eport 12/09/16R2eport 12/02/16; due to the Thanksgiving Holiday, R2 did not publish a newsletter on 11/25/16; R2eport 11/18/16R2eport 11/11/16R2eport 11/04/16R2eport 10/28/16R2eport 10/21/16R2eport 10/14/16R2eport 10/07/16R2eport 09/30/16R2eport 09/23/16R2eport 09/16/16R2eport 09/09/16R2eport 09/02/16R2eport 08/26/16R2eport 08/19/16R2eport 08/12/16R2eport 08/05/16R2eport 07/29/16R2eport 07/22/16R2eport 07/15/16R2eport 07/08/16R2eport 07/01/16R2eport 06/24/16R2eport 06/17/16R2eport 06/10/16R2eport 06/03/16R2eport 05/27/16R2eport 05/20/16R2eport 05/13/16R2eport 05/06/16R2eport 04/29/16R2eport 04/22/16R2eport 04/15/16R2eport 04/08/16R2eport 04/01/16R2eport 03/25/16R2eport 03/18/16R2eport 03/11/16R2eport 03/04/16R2eport 02/26/16R2eport 02/19/16R2eport 02/12/16R2eport 02/05/16R2eport 01/29/16R2eport 01/22/16R2eport 01/15/16R2eport 01/08/16R2eport 12/30/15R2eport 12/18/15R2eport 12/11/15R2eport 12/04/15R2eport 11/20/15R2eport 11/13/15R2eport 11/06/15R2eport 10/30/15R2eport 10/23/15R2eport 10/19/15R2eport 10/16/15R2eport 10/09/15R2eport 10/02/15R2eport 09/25/15R2eport 09/18/15R2eport 09/11/15R2eport 09/04/15R2eport 08/28/15R2eport 08/21/15R2eport 08/14/15R2eport 08/07/15R2eport 07/31/15R2eport 07/24/15R2eport 07/14/15R2eport 07/03/15R2eport 06/26/15R2eport 06/19/15R2eport 06/12/15R2eport 06/05/15R2eport 05/29/15R2eport 05/22/15R2eport 05/15/15R2eport 05/08/15R2eport 05/01/15R2eport 04/24/15R2eport 04/17/15R2eport 04/10/15R2eport 04/03/15R2eport 03/27/15R2eport 03/20/15R2eport 03/13/15R2eport 03/06/15R2eport 02/27/15R2eport 02/20/15R2eport 02/13/15R2eport 02/06/15R2eport 01/30/15R2eport 01/23/15R2eport 01/16/15R2eport 01/09/15R2eport 12/24/14;

 

NTW Entries in Tabular Format from our R2eport 11/09/18 are listed below:

 

New This Week (Tabular)

Category (first appearance)

Title (linked)

Sponsor

Deadline (if multiple, first and last presented)

WEEKLY HIGHLIGHT

DEPARTMENT OF DEFENSE

The Defense Health Program; Department of Defense Peer Reviewed Medical Research Program; Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)

Department of Defense

 

NA

 

PIVOT

NEW tool PIVOT, which allows instantaneous access to the funding opportunities that are right for you

PIVOT, https://pivot.cos.com/

 

NA

 

R2 ANNOUNCEMENTS

Research resources is pleased to coordinate grant type specific grant writing groups, pending faculty / researcher interest.  Please let us know (via email to ckk7@columbia.edu) if you are interested in such groups, along with the type of grant and proposed due date(s). 

 

 

RESEARCH SUPPORT SERVICES

Update on Research Support Services, Spring 2018; we are pleased to expand the Research Support Services to also include resubmissions of otherwise eligible R01, P, K, Center and T32 grants (if the services have not yet been utilized)

                                                                                                                                          

 

Mailman School

relative to upcoming NIH Grant Submission Deadlines: 5 weeks prior to submission deadline (Inform R2 of intent to utilize services); 4 weeks prior to submission deadline (science draft for external review); 2 weeks prior to submission deadline (submission for editing services)

FY 19 FRINGE BENEFIT RATES

Fringe Benefits Rates for Fiscal Year Beginning July 1, 2018 (FY 2019)

SPA

 

Effective 07/01/2018 (FY 2019)

NIH LOAN REPAYMENT

NIH Loan Repayment Programs: A Lifeline for Biomedical and Biobehavioral Researchers: Applications Accepted September 1 – November 15

NIH

 

11/15/2018

 

NIH ANNOUNCEMENTS

New (updated) NIH Grants Policy Statement (GPS) Oct 2018

NIH

 

NA; 10/23/2018 (Release Date)

CANCER

REMINDER: CALL FOR PRE-PROPOSALS: Accelerating Cancer Therapeutics 2018-2019

THERAPEUTICS / DRUG DEVELOPMENT: Accelerating Cancer Therapeutics; ACT http://cancer.columbia.edu ;  Translational Therapeutics Resource: TRx http://irvinginstitute.columbia.edu; MEDICAL TECHNOLOGIES / DEVICES:  Biomedical Accelerator | BiomedX (formerly Columbia-Coulter)

http://columbiabiomedx.com

 

11/15/2018

 

 

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)

National Cancer Institute

 

02/11/2019; 02/12/2019 (Expiration)

 

 

Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)

National Cancer Institute; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering

02/11/2019; 02/12/2019 (Expiration)

 

 

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)

 

National Cancer Institute; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke

02/08/2019; 02/09/2019 (Expiration)

 

 

Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)

 

National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke

02/08/2019; 02/09/2019 (Expiration)

 

 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required)

National Cancer Institute

 

02/11/2019; 02/12/2019 (Expiration)

AGING

Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional)

National Institute on Aging

 

06/03/2019; 06/04/2019 (Expiration)

 

Demography and Economics of Aging and AD-ADRD Coordinating Center (R24 Clinical Trial Not Allowed)

National Institute on Aging

 

06/03/2019; 06/04/2019 (Expiration)

ALZHEIMERS DISEASE

Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)

National Institute on Aging

 

06/03/2019; 06/04/2019

 

 

Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

National Institute on Aging

 

04/25/2019; 04/26/2019 (Expiration)

DEMENTIA

Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke; National Institute on Aging

01/04/2019; 01/05/2019 (Expiration)

 

PARKINSONS DISEASE

APDA Center For Advanced Research Funding Opportunity - Letter of Intent

APDA; American Parkinson’s Disease Association; https://www.apdaparkinson.org

12/01/2018

 

PALLIATIVE

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)

National Institute of Nursing Research

 

Standard dates ; Standard AIDS dates ; 01/08/2022 (Expiration)

 

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)

National Institute of Nursing Research

 

Standard dates ; Standard AIDS dates ; 01/08/2022 (Expiration)

MUSIC AND HEALTH

Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

National Center for Complementary and Integrative Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Deafness and Other Communication Disorders; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Behavioral and Social Science Research

02/28/2019; 03/01/2019 (Expiration)

 

Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)

 

National Institute of Neurological Disorders and Stroke; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Mental Health; National Institute of Nursing Research; Office of Behavioral and Social Science Research

02/28/2019; 03/01/2019 (Expiration)

 

 

Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)

 

National Institute of Neurological Disorders and Stroke; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Biomedical Imaging and Bioengineering; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Nursing Research; Office of Behavioral and Social Science Research

02/28/2019; 03/01/2019 (Expiration)

 

MATERNAL AND CHILD HEALTH

Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)

 

Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Standard dates; Standard AIDS dates; 05/08/2019

 

WOMENS HEALTH

Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)

 

Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (ORWH)

Standard dates; Standard AIDS dates; 05/08/2019

 

 

Multidisciplinary Research in Vulvodynia (R01)

 

Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (ORWH)

Any due dates on or after Jan 25, 2018 must use reissued FOA.

FERTILITY

Fertility Status as a Marker for Overall Health (R01)

 

Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Office of Disease Prevention (ODP)

Standard dates; 05/08/2019

 

NASA

DUE DATE for the 2018 MUREP Innovation and Tech Transfer Idea Competition (MITTIC) has been extended to November 16th, 2018

NASA

 

11/16/2018

 

HIV

Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)

 

National Institute of Allergy and Infectious Diseases; National Institute of Mental Health

Standard AIDS dates; 09/08/2021 (Expiration)

 

BLOOD

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

National Heart, Lung, and Blood Institute

10/18/2019; 10/19/2019 (Expiration)

AWARD

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

 

 

John E. Fogarty International Center; National Cancer Institute; National Human Genome Research Institute; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Research on Women's Health

12/04/2018; 11/07/2019; 11/04/2020; 11/05/2020 (Expiration)

 

TRANSLATIONAL

NCATS CTSA Collaborative Funding Available

The National Center for Advancing Translational Sciences (NCATS) at NIH

 

11/01/2018; 03/01/2019; 03/02/2019 (Expiration)

NOTICE OF INTENT

OPIOIDS

Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)

 

National Center for Complementary and Integrative Health; National Cancer Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research

02/08/2019 (First Estimated Due Date)

 

BRAIN

Notice to Extend the Expiration Date and Change Receipt Dates for PAR-18-835 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

 

John E. Fogarty International Center; National Eye Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke

11/07/2019; 11/08/2019

 

 

Notice to Extend the Expiration Date and Change Receipt Dates for PAR-18-836 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

 

John E. Fogarty International Center; National Eye Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke

11/07/2019; 11/08/2019 (Expiration)

 

NIH GRANT WORKSHOPS

NIH Grant Workshops - November 16, 2018; NIH GRANT WORKSHOPS FOR JUNIOR FACULTY AND POSTDOCTORAL RESEARCHERS; FRIDAY, NOVEMBER 16, 2018

CU Office of Academic Affairs

 

11/16/2018

 

FOUNDATION FUNDING

Visualizing and Powering Healthy Lives (with Urban Institute)

RWJF; https://rwjf.org  

11/16/2018

 

RWJF Health Data for Action: Leveraging Health Data for Actionable Insights (Data Access Award)

RWJF, https://rwjf.org

12/14/2018 (Application)

 

Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

https://www.rwjf.org

Open

 

Leadership for Better Health: National Program Center

RWJF; https://www.rwjf.org

12/13/2018

COLLABORATIVE

Funding opportunity for conducting extramural-intramural collaborative research projects at the NIH Clinical Center;

[1] PAR-18-950 entitled “Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)”

[2] PAR-18-951 entitled “Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)”  

NIH

[1] PAR-18-950; 12/11/2018; 12/11/2019; 12/11/2020; 12/12/2020 (Expiration) 

[2] PAR-18-951; 04/15/2019; 04/15/2020; 04/15/2021; 04/16/2021 (Expiration)

 

IRVING INSTITUTE

Irving Institute Translational Therapeutics Accelerator (TRx) Pilot RFA

Irving Institute

 

11/15/2018 (Pre-Proposals)

 

 

TL1 Training Programs Postdoctoral

 

Irving Institute

 

12/14/2018 (Priority Deadline, rolling admission thereafter)

 

Irving Institute TL1 Training Programs Doctoral

 

Irving Institute

 

12/14/2018 (Priority Deadline, rolling admission thereafter)

RESEARCH RESOURCES INFORMATION SESSION

MyGrants, A Secure Analytic Dashboard to Assist PIs in Managing their Research Funded Projects at-a-Glance

 

Research Resources

 

Thursday December 13, 2018 (12/13/2018), 3:30 PM – 5:00 PM; Hess Student Commons

ASPPH WEEKLY NEWSLETTER

ASPPH WEEKLY NEWSLETTER, 11/09/18

http://aspph.org

NA

STANDARD DUE DATES

Standard Due Dates

                                                                                                                                                                                              

 

https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm

 

 

 

NEW THIS WEEK [NTW]

 

Funding opportunities and announcements listed in the “New this Week” section will be moved to the main body of the newsletter in the following weeks. They are presented and hyperlinked (in the posted .pdf version of the newsletter) in the following order:

 

 

WEEKLY HIGHLIGHT; DEPARTMENT OF DEFENSE; PIVOT; R2 ANNOUNCEMENTS; RESEARCH SUPPORT SERVICES; FY 19 FRINGE BENEFIT RATES; NIH LOAN REPAYMENT; NIH ANNOUNCEMENTS; CANCER; AGING; ALZHEIMERS DISEASE; DEMENTIA; PARKINSONS DISEASE; PALLIATIVE; MUSIC AND HEALTH; MATERNAL AND CHILD HEALTH; WOMENS HEALTH; FERTILITY; NASA; HIV; BLOOD; AWARD; TRANSLATIONAL; NOTICE OF INTENT; OPIOIDS; BRAIN; NIH GRANT WORKSHOPS; FOUNDATION FUNDING; COLLABORATIVE; IRVING INSTITUTE; RESEARCH RESOURCES INFORMATION SESSION; ASPPH WEEKLY NEWSLETTER; STANDARD DUE DATES

 

 

 

[NTW] [WEEKLY HIGHLIGHT/DEPARTMENT OF DEFENSE]
The Defense Health Program; Department of Defense Peer Reviewed Medical Research Program; Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)

Sponsor: Department of Defense

Deadline(s): NA

Contact: Point of Contact: CDMRP Public Affairs; 301-619-9783 ; usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil

Link(s): http://cdmrp.army.mil/pubs/press/2019/19prmrppreann           

Additional Information: Anticipated Funding Opportunities for Peer Reviewed Medical Research Program; The anticipated funding opportunities for the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP) were announced yesterday. This is a very broad program, supporting a number of diseases and topic areas. The actual funding announcements are anticipated to be released later this month.; It is easier to read the announcement via this link, rather than the original announcement below: http://cdmrp.army.mil/pubs/press/2019/19prmrppreann; Feel free to share this widely within your departments.  There are opportunities available for postdocs all the way to the full professor level.; You can subscribe to be alerted on the release of these specific funding opportunities (PRMRP), or others offered by the DoD, by selecting your area of interest at https://ebrap.org/eBRAP/programSubscription/Subscribe.htm.; [brought to our attention by] Stephanie F. Scott, MS, CRA; Director of Policy and Research Development; Columbia Research; Sponsored Projects Administration; sfs2110@cumc.columbia.edu ; Anticipated Funding Opportunities for Peer Reviewed Medical Research Program; The FY19 Defense Appropriations Act provides $350 million (M) to the Department of Defense Peer Reviewed Medical Research Program (PRMRP) to support or medical research projects of clear scientific merit and direct relevance to military health.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA), J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP). ; The PRMRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications.  FY19 PRMRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in November 2018.  Pre-application and application deadlines will be available when the Program Announcements are released.  This pre-announcement should not be construed as an obligation by the government.; The vision and mission of the PRMRP is improve the health, care, and well-being of all military Service members, Veterans, and beneficiaries by encouraging, identifying, selecting, and managing medical research projects of clear scientific merit and direct relevance to military health.; Congressionally Directed Topic Areas:  All applications submitted to the PRMRP must address at least one of the FY19 PRMRP Congressionally directed topic areas. ; A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://ebrap.org/eBRAP/public/index.htm prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.; Applications must be submitted through the federal government's single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under "Email Subscriptions" on the eBRAP homepage at https://ebrap.org/eBRAP/public/index.htm ; For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website http://cdmrp.army.mil/  ; Point of Contact: CDMRP Public Affairs; 301-619-9783; usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil ; The FY19 PRMRP Topic Areas are as follows: [*] Acute Lung Injury; [*] Antimicrobial Resistance; [*] Arthritis; [*] Burn Pit Exposure; [*] Cardiomyopathy; [*] Cerebellar Ataxia;  [*] Chronic Migraine and Post-Traumatic Headache;  [*] Congenital Heart Disease; [*] Constrictive Bronchiolitis; [*] Diabetes; [*] Dystonia; [*] Eating Disorders; [*] Emerging Infectious Diseases; [*] Epidermolysis Bullosa; [*] Focal Segmental Glomerulosclerosis; [*] Frontotemporal Degeneration; [*] Guillain-Barré Syndrome; [*] Hemorrhage Control; [*] Hepatitis B; [*] Hereditary Angioedema; [*] Hydrocephalus; [*] Immunomonitoring of Intestinal Transplants; [*] Inflammatory Bowel Diseases; [*] Interstitial Cystitis; [*] Lung Injury; [*] Metals Toxicology; [*] Mitochondrial Disease; [*] Musculoskeletal Disorders; [*] Myotonic Dystrophy; [*] Nanomaterials for Bone Regeneration; [*] Nutrition Optimization; [*] Pancreatitis; [*] Pathogen-Inactivated Blood Products; [*] Polycystic Kidney Disease; [*] Post-Traumatic Osteoarthritis; [*] Pressure Ulcers; [*] Pulmonary Fibrosis; [*] Resilience Training; [*] Respiratory Health; [*] Rett Syndrome; [*] Rheumatoid Arthritis; [*] Scleroderma; [*] Sleep Disorders; [*] Spinal Muscular Atrophy; [*] Tinnitus; [*] Tissue Regeneration; [*] Tuberculosis; [*] Vascular Malformations; [*] Women's Heart Disease; The following mechanisms are planned for release: http://cdmrp; army; mil/pubs/press/2019/19prmrppreann ; [1] Clinical Trial Award: [*] Assistant Professor level or above (or equivalent); [*] Preproposal submission is required; application submission is by invitation only;  [*] Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area(s) of interest;  [*] Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials;  [*] Investigational New Drug or Investigational Device Exemption applications, if needed, should be approved by the Food and Drug Administration before the PRMRP application submission deadline; [*] Funding limit not defined; requested funding must be appropriate for the scope of work proposed; [*]Maximum period of performance is 4 years; [2] Discovery Award: [*] Postdoctoral fellow or clinical fellow (or equivalent) and above; [*]Supports the exploration of a highly innovative new concept or untested theory; [*] Not intended to support the logical progression of an already established line of questioning; [*] Clinical trials will not be funded; [*]Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborators, and their organization(s); [*]  Maximum of $200,000 for direct costs (plus indirect costs); [*] Maximum period of performance is 2 year; [3] Focused Program Award: [*] Full Professor level or above (or equivalent); [*] Preproposal submission is required; application submission is by invitation only; [*] Supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal; [*] Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications; [*] Projects may range from exploratory/hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question; [*] Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects; [*] Maximum of $7.2 million for direct costs (plus indirect costs); [*]  Maximum period of performance is 4 years; [4] Investigator-Initiated Research Award: [*] Assistant Professor level or above (or equivalent); [*] Preproposal submission is required; application submission is by invitation only; [*] Supports research that will make an original and important contribution to the field of research or patient care in the topic area(s) of interest; [*] Partnering PI Option available; [*] Clinical trials will not be funded; [*] Maximum of $1.2 million for direct costs (plus indirect costs); [*]  Maximum of $1.5 million for direct costs (plus indirect costs) for applications including a Partnering PI Option; [*] Maximum period of performance is 3 years; [6]  Technology/ Therapeutic Development Award: [*] Assistant Professor level or above (or equivalent); [*] Supports the translation of promising preclinical findings into clinical applications for prevention, detection, diagnosis, treatment, or quality of life; [*] Product-oriented (e.g., device, drug, clinical guidelines); [*] The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product; [*] Clinical trials will not be funded; [*] Preproposal submission is required; application submission is by invitation only; [*] Maximum of $3.0 million for direct costs (plus indirect costs); [*] Maximum period of performance is 3 years

 

 

 

[NTW] [PIVOT]
NEW tool PIVOT, which allows instantaneous access to the funding opportunities that are right for you

Sponsor: PIVOT, https://pivot.cos.com/

Deadline(s): NA

Contact: https://pivot.cos.com/contact_us

Link(s): https://pivot.cos.com/

Additional Information: The Augustus C. Long Health Sciences Library (HSL) and Sponsored Projects Administration (SPA) are pleased to introduce you to a new tool PIVOT, which allows instantaneous access to the funding opportunities that are right for you.; Start using PIVOT at: https://pivot.cos.com/ and sign up for an account using your Columbia University email address. ; PIVOT strengths: (*) Editorially curated up-to-date funding opportunities span all disciplines and project types, from health and medicine to humanities, law and education, worth an estimated $49 billion.; (*) A proprietary algorithm that compiles researcher profiles and matches them to current funding opportunities.; HSL and SPA will be collaborating in the coming months in various outreach and training events. In the meantime find video tutorials and other training materials, or if you have questions, please feel free to send them to us via HSL.; For further information about funding sources, including SPIN, visit Columbia Research website. [brought to our attention by Stephanie Scott]

 

 

[NTW] [R2 ANNOUNCEMENTS]

Research resources is pleased to coordinate grant type specific grant writing groups, pending faculty / researcher interest.  Please let us know (via email to ckk7@columbia.edu) if you are interested in such groups, along with the type of grant and proposed due date(s). 

 

 

[NTW] [RESEARCH SUPPORT SERVICES]
Update on Research Support Services, Spring 2018; we are pleased to expand the Research Support Services to also include resubmissions of otherwise eligible R01, P, K, Center and T32 grants (if the services have not yet been utilized)

Sponsor: Mailman School                                                                                          

Deadline(s): relative to upcoming NIH Grant Submission Deadlines: 5 weeks prior to submission deadline (Inform R2 of intent to utilize services); 4 weeks prior to submission deadline (science draft for external review); 2 weeks prior to submission deadline (submission for editing services)

Contact: Pam Factor-Litvak (Associate Dean, Research Resources, and Professor of Epidemiology) prf1@columbia.edu; Craig Kandell (Project Coordinator, Research Resources) ckk7@columbia.edu  

Link(s): https://r2eport.files.wordpress.com/2015/05/updateofgrantsupportservicesspring2018gpdf.pdf

Additional Information:

 

Dear Mailman School faculty,

 

I want to give you an update on Research Support Services—the School’s new program for pre-submission external review and final editing. As Dean Fried wrote in October, the program is geared “to support faculty in preparing grant applications with the highest chance of success.”

 

I’m happy to report that those using the services this fall have found them valuable. Katherine Keyes in Epidemiology spoke enthusiastically at the recent Assembly: “It was a great experience. I got to focus on the science without having to deal with any of the administrative aspects. I got really good feedback. I will be using these services again.”

 

In my estimation, all the grants were greatly improved by these services. Of course, the ultimate test is how they are scored and funded. As soon I have that information, I will share it with you.

 

I encourage everyone to take advantage of Research Support Services to give your grants a competitive advantage. Please keep in mind the following deadlines:

 

  • 5 weeks prior to submission deadline—Inform Research Resources (via Craig Kandell at ckk7@cumc.columbia.edu) if you plan on using Research Support Services with information about they the type of grant at least five weeks prior to the grant due date. If you seek external review, please provide the name and contacts of at least three potential reviewers so we can reach out to them in your order of preference.

 

  • 4 weeks prior to submission deadline —Send us your science draft for external review three to four weeks prior to submission. We will forward it to the external reviewer. Generally, they provide feedback within a week.

 

  • 2 weeks prior to submission deadline —For editorial services, send us your manuscript at least 10 days ahead of the deadline. We will make arrangements with the editor. Comments will be returned to Craig and the PI for finalization and submission within a few days.

 

Please keep in mind that it may take you a day or two to incorporate comments and edits. For best results, get in touch with us prior to these deadlines.

 

Research Support Services cover first-time submissions, and we are pleased to expand the service to encompass resubmissions (if the support services have not been utilized for the grant) of R01, P, K, Center, T32, or other complex NIH proposals by full-time faculty with primary appointments in the School. I am available to provide feedback for grants that utilize this service and also for other grant types (such as R21s) that are ineligible for the services.

 

If you have any questions about your eligibility or the above process, please visit Research Resources online or contact me at prf1@columbia.edu.

 

Best wishes,

Pam Factor-Litvak

 

 

 

[NTW] [FY 19 FRINGE BENEFIT RATES]
Fringe Benefits Rates for Fiscal Year Beginning July 1, 2018 (FY 2019)

Sponsor: SPA

Deadline(s): Effective 07/01/2018 (FY 2019)

Contact: Any questions about the government fringe rate should be directed to AskRPIC@columbia.edu.

Link(s): https://finance.columbia.edu/content/fringe-benefit-rates

Additional Information: Fringe Benefits Rates for Fiscal Year Beginning July 1, 2018 (FY 2019); Principal Investigators; Sponsored Projects Administrators; From:    Mark Hawkins, Vice President, Finance & Controller; Rudi Odeh-Ramadan, Vice President for Research Administration; We are writing to inform you that, based on the approval obtained from the Federal government, the fringe rate applicable to government grants and contracts will decrease from 30.3% to 28.2%, effective July 1, 2018.  For all funding sources other than government grants and contracts, the fringe benefit rate is 30.5%.; Please note that you may wish to take this opportunity to review the impact the change in the fringe benefits recovery rate may have on the allocation of personnel related costs for the remainder of the grant life cycle.; For information regarding student employees working during the academic year or summer, refer to https://finance.columbia.edu/content/fringe-benefit-rates. ; The PAC team will process fringe adjustments for all FY19 payroll activity that has been recorded since July 1,2018 prior to the September close. ; The rate agreement is available on the SPA website on the Institutional Information page and on the Finance Gateway at https://finance.columbia.edu/content/fringe-benefit-rates. ; Any questions about the government fringe rate should be directed to AskRPIC@columbia.edu.

 

 

 

 

[NTW] [NIH LOAN REPAYMENT]
NIH Loan Repayment Programs: A Lifeline for Biomedical and Biobehavioral Researchers: Applications Accepted September 1 – November 15

Sponsor: NIH

Deadline(s): 11/15/2018

Contact: If you have questions, or want more details, visit www.lrp.nih.gov, send an email to lrp@nih.gov or call the LRP information center at 866-849-4047 (Mon-Fri 9:00 a.m. to 5:00 p.m. EST).

Link(s): https://www.lrp.nih.gov/

https://nexus.od.nih.gov/all/2018/09/28/nih-loan-repayment-programs-a-lifeline-for-biomedical-and-biobehavioral-researchers-applications-accepted-september-1-november-15/

Additional Information: By the time many researchers have completed their education and training, they have amassed on average $160,000 in student loan debt. The NIH Loan Repayment Programs (LRPs) are a set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The LRPs counteract early-career researchers’ financial pressure by repaying up to $35,000 annually ($70,000 over a two-year contract) of a researcher’s qualifying educational debt in return for a commitment to engage in research areas important to the mission of NIH. https://nexus.od.nih.gov/all/2018/09/28/nih-loan-repayment-programs-a-lifeline-for-biomedical-and-biobehavioral-researchers-applications-accepted-september-1-november-15/ [*]

 

 

 

[NTW] [NIH ANNOUNCEMENTS]
New (updated) NIH Grants Policy Statement (GPS) Oct 2018

Sponsor: NIH

Deadline(s): NA; 10/23/2018 (Release Date)

Contact: Please direct all inquiries to: NIH Office of Policy for Extramural Research Administration; Telephone: 301-435-0949; Email:  grantspolicy@mail.nih.gov ; As always, if you have any questions, please feel free to reach out to your SPA Project Officer

Link(s): https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-021.html

https://grants.nih.gov/policy/nihgps/index.htm

https://grants.nih.gov/grants/policy/nihgps/Significant_Changes_NIHGPS_Oct2018.pdf

Additional Information: [SPA News] New NIH Grants Policy Statement (GPS) Oct 2018; The National Institutes of Health (NIH) has released its latest version of their Grants Policy Statement (NIHGPS, rev Oct 2018). It is applicable to all NIH grants and cooperative agreements with budget periods beginning October 1st, 2018. It supersedes the previous version (NIHGPS, rev Oct 2017).  You can read the full announcement here: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-021.html ; The HTML and PDF versions of the NIHGPS can be found at https://grants.nih.gov/policy/nihgps/index.htm. ; NIH updates the NIHGPS every October to incorporate policy announcements that were released during the last year, and to clarify existing policies. Therefore, this revised NIHGPS does not introduce any new policies for the first time.; A summary of significant changes can be found here: https://grants.nih.gov/grants/policy/nihgps/Significant_Changes_NIHGPS_Oct2018.pdf ; As always, if you have any questions, please feel free to reach out to your SPA Project Officer. [brought to our attention by] Stephanie F. Scott, MS, CRA; Director of Policy and Research Development; Columbia | Research; Sponsored Projects Administration; Main Campus: (212) 854-0606; Cell Phone: (646) 248-8573; Email: stephanie.scott@columbia.edu; or sfs2110@cumc.columbia.edu ; Website: https://spa.columbia.edu/

 

 

[NTW] [CANCER]
REMINDER: CALL FOR PRE-PROPOSALS: Accelerating Cancer Therapeutics 2018-2019

Sponsor: THERAPEUTICS / DRUG DEVELOPMENT: Accelerating Cancer Therapeutics; ACT http://cancer.columbia.edu ;  Translational Therapeutics Resource: TRx http://irvinginstitute.columbia.edu; MEDICAL TECHNOLOGIES / DEVICES:  Biomedical Accelerator | BiomedX (formerly Columbia-Coulter) http://columbiabiomedx.com

Deadline(s): 11/15/2018

Contact: THERAPEUTICS / DRUG DEVELOPMENT: Accelerating Cancer Therapeutics; act@cumc.columbia.edu;  Translational Therapeutics Resource; TRxResource@columbia.edu ; MEDICAL TECHNOLOGIES / DEVICES:  Biomedical Accelerator:  | BiomedX (formerly Columbia-Coulter): BiomedX@columbia.edu

Link(s): https://r2eport.files.wordpress.com/2014/04/l2m-life-sciences_rfa-2018-2019-cycle2.pdf

Additional Information: REMINDER: CALL FOR PRE-PROPOSALS: Accelerating Cancer Therapeutics 2018-2019; Dear Colleagues, On behalf of the Cancer Center Leadership, please note the Call for Pre-proposals from the Columbia Lab To Market Accelerators, Life Science Resources.  The pre-applications are due on Thursday, November 15, 2018.; BRING YOUR IDEAS TO LIFE COLUMBIA LAB-TO-MARKET ACCELERATORS LIFE SCIENCE RESOURCES; Moving cutting-edge university research out of the lab to benefit society; Accelerator programs aim to catalyze innovation via support to interdisciplinary teams, with the goal of increasing the potential for private investment towards continued product development, clinical testing, and, ultimately, improved patient care and healthcare outcomes.  Selected teams work closely with business, legal and regulatory experts to define commercially-relevant hypotheses for research towards technical and business proof-of-concepts.; CALL FOR APPLICATIONS: Project funding, education and support for interdisciplinary teams working to advance innovative ideas with the potential to positively impact health outcomes.; PRE-PROPOSALS due by THURSDAY, NOVEMBER 15, 2018.; THERAPEUTICS / DRUG DEVELOPMENT: [*]  Accelerating Cancer Therapeutics (ACT); [*]  Translational Therapeutics Resource (TRx); MEDICAL TECHNOLOGIES / DEVISES: [*] Columbia Biomedical Technology Accelerator (formally Columbia-Coulter Translational Research Partnership) [*]

 

 

 

[NTW] [CANCER]
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)

Sponsor: National Cancer Institute

Deadline(s): 02/11/2019; 02/12/2019 (Expiration)

Contact: Scientific/Research Contact(s); Robert H. Shoemaker, Ph.D.; National Cancer Institute (NCI); Telephone: 240-276-7077; Email: Shoemakr@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-012.html

 

 

 

[NTW] [CANCER]
Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)

Sponsor: National Cancer Institute; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering

Deadline(s): 02/11/2019; 02/12/2019 (Expiration)

Contact: Scientific/Research Contact(s); Kevin Howcroft, Ph.D.; National Cancer Institute (NCI); Telephone: 240-276-6702; Email: Howcrofk@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-013.html

 

 

 

[NTW] [CANCER]
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)

Sponsor: National Cancer Institute; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke

Deadline(s): 02/08/2019; 02/09/2019 (Expiration)

Contact: Scientific/Research Contact(s); Robert H. Shoemaker, Ph.D.; National Cancer Institute (NCI); Telephone: 240-276-7077; Email: Shoemakr@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-014.html

 

 

 

[NTW] [CANCER]
Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)

Sponsor: National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke

Deadline(s): 02/08/2019; 02/09/2019 (Expiration)

Contact: Scientific/Research Contact(s); Nancy Boudreau, PhD; National Cancer Institute (NCI); Telephone: 240-276-6702; E-mail: nancy.boudreau@nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-015.html

 

 

 

[NTW] [CANCER]
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required)

Sponsor: National Cancer Institute

Deadline(s): 02/11/2019; 02/12/2019 (Expiration)

Contact: Scientific/Research Contact(s); For questions about the healthcare delivery system aspects of the application: Sarah Kobrin, Ph.D.; National Cancer Institute (NCI); Telephone: 240-276-6931; Email: sarah.kobrin@nih.gov  

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-018.html

 

 

 

[NTW] [AGING]
Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional)

Sponsor: National Institute on Aging

Deadline(s): 06/03/2019; 06/04/2019 (Expiration)

Contact: Scientific/Research Contact(s); Georgeanne E. Patmios; National Institute on Aging (NIA); Telephone: 301-496-3136; Email: PatmiosG@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-001.html

 

 

 

[NTW] [AGING]
Demography and Economics of Aging and AD-ADRD Coordinating Center (R24 Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Deadline(s): 06/03/2019; 06/04/2019 (Expiration)

Contact: Scientific/Research Contact(s); Georgeanne E. Patmios; National Institute on Aging (NIA); Telephone: 301-496-3136; Email: PatmiosG@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-003.html

 

 

[NTW] [ALZHEIMERS DISEASE]
Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)

Sponsor: National Institute on Aging

Deadline(s): 06/03/2019; 06/04/2019

Contact: Scientific/Research Contact(s); Georgeanne E. Patmios; National Institute on Aging (NIA); Telephone: 301-496-3136; Email: PatmiosG@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-002.html

 

 

 

[NTW] [ALZHEIMERS DISEASE]
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Deadline(s): 04/25/2019; 04/26/2019 (Expiration)

Contact: Scientific/Research Contact(s); Nina B. Silverberg, Ph.D.; National Institute on Aging (NIA); Telephone: 301-496-9350; Email: silverbergn@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-004.html

 

 

[NTW] [DEMENTIA]
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke; National Institute on Aging

Deadline(s): 01/04/2019; 01/05/2019 (Expiration)

Contact: Scientific/Research Contact(s); Debra Babcock, PhD, MD; National Institute of Neurological Disorders and Stroke (NINDS); Telephone: 301-496-9964; Email: mailto:dbabcock@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-013.html

 

 

 

[NTW] [PARKINSONS DISEASE]
APDA Center For Advanced Research Funding Opportunity - Letter of Intent

Sponsor: APDA; American Parkinson’s Disease Association; https://www.apdaparkinson.org

Deadline(s): 12/01/2018

Contact: 718-981-8491, Heather Gray - hgray@apdaparkinson.org

Link(s): https://www.apdaparkinson.org/research/advanced-centers/   

Additional Information: APDA Center For Advanced Research Funding for the US based investigators; The American Parkinson’s Disease Association (APDA) is soliciting applications for APDA Center For Advanced Research Funding for the US based investigators. The Center should involve a multidisciplinary team of scientific and clinical investigators well positioned to engage in innovative, high impact PD research. Support for the Centers is an annual award of $100,000. Physicians and Scientists from the US can apply. As the deadline is fast approaching, we are reaching to see if your team would be interested. [brought to our attention by trialect.com

 

 

[NTW] [PALLIATIVE]
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)

Sponsor: National Institute of Nursing Research

Deadline(s): Standard dates ; Standard AIDS dates ; 01/08/2022 (Expiration)

Contact: Scientific/Research Contact(s); Karen A. Kehl, Ph.D.; National Institute of Nursing Research (NINR); Telephone: 301-594-8010; Email: kehlka@nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html

 

 

 

[NTW] [PALLIATIVE]
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)

Sponsor: National Institute of Nursing Research

Deadline(s): Standard dates ; Standard AIDS dates ; 01/08/2022 (Expiration)

Contact: Scientific/Research Contact(s); Karen A. Kehl, Ph.D.; National Institute of Nursing Research (NINR); Telephone: 301-594-8010; Email: kehlka@nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html

 

 

[NTW] [MUSIC AND HEALTH]
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

Sponsor: National Center for Complementary and Integrative Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Deafness and Other Communication Disorders; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Behavioral and Social Science Research

Deadline(s): 02/28/2019; 03/01/2019 (Expiration)

Contact: Scientific/Research Contact(s); Wen G. Chen, Ph.D.; National Center for Complementary and Integrative Health (NCCIH); Telephone: 301-451-3989; Email: chenw@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-001.html  

 

 

[NTW] [MUSIC AND HEALTH]
Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)

Sponsor: National Institute of Neurological Disorders and Stroke; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Mental Health; National Institute of Nursing Research; Office of Behavioral and Social Science Research

Deadline(s): 02/28/2019; 03/01/2019 (Expiration)

Contact: Scientific/Research Contact(s); Primary Contact: Robert Riddle, Ph.D.; National Institute of Neurological Disorders and Stroke (NINDS); Telephone:301-496-5745; Email: riddler@ninds.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-008.html

 

 

 

[NTW] [MUSIC AND HEALTH]
Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)

Sponsor: National Institute of Neurological Disorders and Stroke; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Biomedical Imaging and Bioengineering; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Nursing Research; Office of Behavioral and Social Science Research

Deadline(s): 02/28/2019; 03/01/2019 (Expiration)

Contact: Scientific/Research Contact(s); Primary Contact: Robert Riddle, Ph.D.; National Institute of Neurological Disorders and Stroke (NINDS); Telephone:301-496-5745; Email: riddler@ninds.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-009.html

 

 

[NTW] [MATERNAL AND CHILD HEALTH]
Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)

Sponsor: Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Deadline(s): Standard dates; Standard AIDS dates; 05/08/2019

Contact: Scientific/Research Contact(s); Nahida Chakhtoura, MD, MsGH (Obstetrics); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Telephone: 301-435-6872; Email: nahida.chakhtoura@nih.gov 

Link(s): https://grants.nih.gov/grants/guide/pa-files/pa-18-092.html

 

 

 

[NTW] [WOMENS HEALTH]
Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)

Sponsor: Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (ORWH)

Deadline(s): Standard dates; Standard AIDS dates; 05/08/2019

Contact: Scientific/Research Contact(s); Susan Meikle, M.D., M.S.P.H.; Eunice Kennedy Shriver National Institute of Child Health and Human; Development (NICHD); Telephone: 301-273-8541; Email: meikles@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PA-18-096.html    

 

 

 

[NTW] [WOMENS HEALTH]
Multidisciplinary Research in Vulvodynia (R01)

Sponsor: Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (ORWH)

Deadline(s): Any due dates on or after Jan 25, 2018 must use reissued FOA.

Contact: Scientific/Research Contact(s); Susan Meikle, M.D., M.S.P.H.; Eunice Kennedy Shriver National Institute of Child Health and Human; Development (NICHD); Telephone: 301-273-8541; Email: meikles@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PA-16-102.html

http://www.grants.gov/web/grants/view-opportunity.html?oppId=281604;

http://www.infoed.org/new_spin/spin_prog.asp?52449;

Additional Information: Any due dates on or after Jan 25, 2018 must use reissued FOA.[a reissued link has not been provided]

 

 

[NTW] [FERTILITY]
Fertility Status as a Marker for Overall Health (R01)

Sponsor: Department of Health and Human Services; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Office of Disease Prevention (ODP)

Deadline(s): Standard dates; 05/08/2019

Contact: Scientific/Research Contact(s); Susan Taymans, PhD; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Telephone: 301-496-6517; Email: TaymansS@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PA-17-091.html [*]

 

 

[NTW] [NASA]
DUE DATE for the 2018 MUREP Innovation and Tech Transfer Idea Competition (MITTIC) has been extended to November 16th, 2018

Sponsor: NASA

Deadline(s): 11/16/2018

Contact: Email questions to HQ-MITTIC@mail.nasa.gov

Link(s): http://www.spaceref.com/news/viewpr.html?pid=53347 

https://nspires.nasaprs.com/external/index.do

Additional Information: EXTENSION: Due date is Friday, November 16th, 2018 - MUREP Innovation and Tech Transfer Idea Competition (MITTIC) 2018; REMINDER: DUE DATE for the 2018 MUREP Innovation and Tech Transfer Idea Competition (MITTIC) has been extended to November 16th, 2018; Announcement Number: MITTIC2018, Released September 27, 2018; MUREP Innovation and Tech Transfer Idea Competition (MITTIC) is a spinoff challenge established to develop new ideas for commercialization by seeking concept papers from multi-disciplinary student teams enrolled at a Minority Serving Institution (MSI). The due date for concept papers being submitted to NSPIRES in response to MITTIC is NOVEMBER 16, 2018.; [*]  Proposers are required to register with NSPIRES for the submission. To register in NSPIRES please go to http://nspires.nasaprs.com.; [*] Please request affiliation with the NASA OE Fellowship Submission Office, if you experience problems affiliating with your organization.; ​Full details for the MITTIC (open to Minority Serving Institutions) can be found at the following link: https://nspires.nasaprs.com/external/index.do ; Email questions to HQ-MITTIC@mail.nasa.gov

 

 

 

[NTW] [HIV]
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)

Sponsor: National Institute of Allergy and Infectious Diseases; National Institute of Mental Health

Deadline(s): Standard AIDS dates; 09/08/2021 (Expiration)

Contact: Scientific/Research Contact(s); Adeola Adeyeye, M.D.; National Institute of Allergy and Infectious Diseases (NIAID); Telephone: 240-669-5005; Email: adeyeyeao@niaid.nih.gov 

Link(s): https://grants.nih.gov/grants/guide/pa-files/PA-19-050.html

 

 

[NTW] [BLOOD]
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Sponsor: National Heart, Lung, and Blood Institute

Deadline(s): 10/18/2019; 10/19/2019 (Expiration)

Contact: Scientific/Research Contact(s); Pankaj Qasba, Ph.D.; National Heart, Lung, and Blood Institute (NHLBI); Telephone:  301-435-0050; E-mail: qasbap@nhlbi.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-19-048.html

 

 

 

[NTW] [AWARD]
Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Sponsor: John E. Fogarty International Center; National Cancer Institute; National Human Genome Research Institute; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Research on Women's Health

Deadline(s): 12/04/2018; 11/07/2019; 11/04/2020; 11/05/2020 (Expiration)

Contact: Scientific/Research Contact(s); Christine Jessup, Ph.D; Fogarty International Center (FIC); Telephone: 301-496-1653; Email: Christine.Jessup@nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-19-051.html   

 

 

[NTW] [TRANSLATIONAL]
NCATS CTSA Collaborative Funding Available

Sponsor: The National Center for Advancing Translational Sciences (NCATS) at NIH

Deadline(s): 11/01/2018; 03/01/2019; 03/02/2019 (Expiration)

Contact: Scientific/Research Contact(s); Erica Rosemond, Ph.D.; National Center for Advancing Translational Sciences (NCATS); Telephone: 301-594-8927; Email: rosemonde@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PA-16-328.html

Additional Information: NCATS CTSA Collaborative Funding Available; The National Center for Advancing Translational Sciences (NCATS) at NIH has funding available to explore novel, generalizable approaches to important translational science questions across multiple CTSA sites. Three mechanisms are available – R21, U01 and Admin Supplements. All require collaboration between two/three or more CTSA sites (there are currently 62 nationwide). We strongly encourage any interested and eligible investigator to apply.; We are happy to help interested investigators by assisting you explore partnerships with other CTSA sites, make connections with mentors locally, and providing the required letter of support. Please contact Helena Rincón at hr2016@cumc.columbia.edu or 212-305-0427 for further information.; PA-16-328: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program; Posted 6/14/2016, remaining deadline March 1, 2019; $300K per year, up to two years https://grants.nih.gov/grants/guide/pa-files/PA-16-328.html [*]

 

 

 

[NTW] [NOTICE OF INTENT/OPIOIDS]
Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)

Sponsor: National Center for Complementary and Integrative Health; National Cancer Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research

Deadline(s): 02/08/2019 (First Estimated Due Date)

Contact: Please direct all inquiries to: Wendy Weber, ND, Ph.D, M.P.H.; National Center for Complementary and Integrative Health (NCCIH); 301-402-1272; Wendy.Weber@nih.gov

Link(s): https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-004.html

 

 

 

[NTW] [BRAIN]
Notice to Extend the Expiration Date and Change Receipt Dates for PAR-18-835 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

Sponsor: John E. Fogarty International Center; National Eye Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke

Deadline(s): 11/07/2019; 11/08/2019

Contact: Please direct all inquiries to: Kathleen Michels, Ph.D.; Fogarty International Center (FIC); Telephone:  301-496-1653; Email:  brainfic@nih.gov

Link(s): https://grants.nih.gov/grants/guide/notice-files/NOT-TW-18-007.html


 

[NTW] [BRAIN]
Notice to Extend the Expiration Date and Change Receipt Dates for PAR-18-836 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

Sponsor: John E. Fogarty International Center; National Eye Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke

Deadline(s): 11/07/2019; 11/08/2019 (Expiration)

Contact: Please direct all inquiries to: Kathleen Michels, Ph.D.; Fogarty International Center (FIC); Telephone:  301-496-1653; Email:  brainfic@nih.gov

Link(s): https://grants.nih.gov/grants/guide/notice-files/NOT-TW-18-008.html

 

 

[NTW] [NIH GRANT WORKSHOPS]
NIH Grant Workshops - November 16, 2018; NIH GRANT WORKSHOPS FOR JUNIOR FACULTY AND POSTDOCTORAL RESEARCHERS; FRIDAY, NOVEMBER 16, 2018

Sponsor: CU Office of Academic Affairs

Deadline(s): 11/16/2018

Contact: For more information about these sessions, please contact us at Office_Acad_Affairs@cumc.columbia.edu

Link(s): https://www.ps.columbia.edu/administration/academic-affairs/faculty-development/faculty-diversity/programs

Additional Information: NIH Grant Workshops - November 16, 2018; NIH GRANT WORKSHOPS FOR JUNIOR FACULTY AND POSTDOCTORAL RESEARCHERS; FRIDAY, NOVEMBER 16, 2018; SPEAKERS: [1] Joan M. Lakoski, PhD; West Virginia University School of Pharmacy; joan.lakoski@hsc.wvu.edu; [2] Robert J. Milner, PhD; University of Massachusetts; Medical School; robert.milner@umassmed.edu ; GOAL:  To provide guidance on applications for NIH career development (K awards) and crafting effective specific aims; OBJECTIVES:  By the completion of this session, participants will be able to: [*] Choose the appropriate type of career development or training award for their career stage and situation; [*] Complete and submit an application for a NIH career development award using strategies for a successful grant proposal; [*] Write an effective specific aims page; You may attend one or all of the sessions.; Registration for each session is required.; [1] “Navigating NIH: An Overview of NIH and the Grant Review Process”; Date: November 16, 2018; Time: 9:30 am – 11:00 am; Location: College of Physicians and Surgeons, Amp 1 (first floor, 630 W 168th St.); Registration (required): register here; This session provides a guide to navigating NIH, the grant review process, and the essential steps to complete and submit an application.; [2] “Know your K (K01, K08, K23 Awards)”; Date: November 16, 2018; Time: 11:00 am – 12:00 pm; Location: College of Physicians and Surgeons, Amp 1 (first floor, 630 W 168th St.); Institutes of Health (NIH) Mentored Career Development (“K”) Awards are a primary grant mechanism for supporting new investigators. This workshop explores the range of K Awards and the components of the application for the awards.; [3] “Know your Kangaroo: Pathway to Independence K99/R00”; Date: November 16, 2018; Time: 1:00 pm – 2:00 pm; Location: College of Physicians and Surgeons, Amp 1 (first floor, 630 W 168th St.); This session provides an overview of the NIH program that gives promising postdoctoral scientists the opportunity to receive both mentored (K) and independent research support (R) from the same award. It features success stories from colleagues who have received these awards.; [4] “Writing Effective Specific Aims”; Date: November 16, 2018; Time: 2:00 pm – 4:00 pm ; Location: College of Physicians and Surgeons, Amp 1 (first floor, 630 W 168th St.); The most important section for the development of a NIH grant application is the Specific Aims section. This section becomes the master plan for the rest of your proposal and a key part that all reviewers read. This session provides insight into the elements of a strong Specific Aims section with time provided for participants to work on specific aims for projects and/or proposals they are developing.; For more information about these sessions, please contact us at Office_Acad_Affairs@cumc.columbia.edu [*]

 

 

[NTW] [FOUNDATION FUNDING]

Visualizing and Powering Healthy Lives (with Urban Institute)

Sponsor: RWJF; https://rwjf.org  

Deadline(s): 11/16/2018

Contact: usaleep@urban.org

Link(s): https://usaleep.urban.org

 

 

[NTW] [FOUNDATION FUNDING]

RWJF Health Data for Action: Leveraging Health Data for Actionable Insights (Data Access Award)

Sponsor: RWJF, https://rwjf.org

Deadline(s): 12/14/2018 (Application)

Contact: healthdataforaction@rwjf.org

Link(s): https://www.rwjf.org/en/library/funding-opportunities/2018/health-data-for-action-leveraging-health-data-for-actionable-insights.html

 

 

[NTW] [FOUNDATION FUNDING]

Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Sponsor: https://www.rwjf.org

Deadline(s): Open

Contact: evidenceforaction@ucsf.edu

Link(s): https://www.rwjf.org/en/library/funding-opportunities/2015/evidence-for-action-investigator-initiated-research-to-build-a-culture-of-health.html

 

 

[NTW] [FOUNDATION FUNDING]
Leadership for Better Health: National Program Center

Sponsor: RWJF; https://www.rwjf.org

Deadline(s): 12/13/2018

Contact: hprsnpc@rwjf.org

Link(s): https://www.rwjf.org/en/library/funding-opportunities/2018/leadership-for-better-health-npc.html

 

 

 

[NTW] [COLLABORATIVE]
Funding opportunity for conducting extramural-intramural collaborative research projects at the NIH Clinical Center;

[1] PAR-18-950 entitled “Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)”

[2] PAR-18-951 entitled “Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)”

Sponsor: NIH

Deadline(s): [1] PAR-18-950; 12/11/2018; 12/11/2019; 12/11/2020; 12/12/2020 (Expiration) 

[2] PAR-18-951; 04/15/2019; 04/15/2020; 04/15/2021; 04/16/2021 (Expiration)

Contact: [multiple]; Scientific/Research Contact(s); CLINICAL CENTER PARTNERSHIP; Hana Smith, MS, Health Science Specialist; NIH Office of Clinical Research (OD); Telephone: 301-496-4121; Email: ClinicalCtrPartner@mail.nih.gov ; NCI; Minkyung (Min) H. Song, PhD; National Cancer Institute (NCI); Telephone: 240-276-6139; Email: songm@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/par-18-950.html

https://grants.nih.gov/grants/guide/pa-files/par-18-951.html

Additional Information: Funding opportunity for conducting extramural-intramural collaborative research projects at the NIH Clinical Center; Dear Investigators, We would like to inform you of the availability of the following two re-issuance funding opportunity announcements (FOAs): [1] PAR-18-950 entitled “Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)” – Application Due Dates: December 11th in 2018, 2019 and 2020; [2] PAR-18-951 entitled “Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)” - Application Due Dates: April 15th in 2019, 2020 and 2021; The X02 pre-application is the highly-recommended first step in the U01 cooperative agreement application process.; This program is aimed to support extramural-intramural collaborative, “patient-centric translational” research projects that enhance the translation of basic biological discoveries into clinical applications for improved human health by taking advantage of the unique research opportunities available at the NIH Clinical Center https://www.cc.nih.gov/translational-research-resources/resources.html .  Specifically, this program promotes partnerships between the NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and provides support for extramural investigators to conduct clinical research projects at the NIH Clinical Center in collaboration with the NIH intramural investigators.  The National Cancer Institute (NCI) encourages well-balanced extramural-intramural contributions towards accomplishing the proposed Aims for the intellectually-challenging collaborative projects.; Applications for this program will be submitted by the extramural institution with active involvement of the intramural investigators in planning, preparing grant applications/resubmissions for, and executing the proposed research projects.  The NIH intramural research partners can be identified at https://intramural.nih.gov/search/index.taf.  Research partners whose X02 pre-application in response to the PAR-18-950 is “meritorious, can be accommodated by the resources of the NIH Clinical Center and the relevant intramural program,” and aligns with the research missions of the participating NIH Institutes, will receive two letters of support from the NIH that must be included in their U01 application/resubmission in response to the PAR-18-951.; In order to be eligible for this program: [*] Each application must include at least one intramural scientist as either a Program Director/Principal Investigator or a collaborator; [*] At least some of the proposed clinical research must be conducted at the NIH Clinical Center by leveraging its diverse resources, expertise and infrastructure; [*] Patients must be seen at the NIH Clinical Center; [*] Application must include a collaboration plan, and must describe the advantages of the intramural/extramural partnership and the utilization of Clinical Center resources; [*] U01 budget (up to $500K direct costs per year for a period of up to 5 years) must delineate extramural costs, intramural costs and Clinical Center costs (the cost of drugs that are the subject of the study only; standard-of-care drugs will be free); and [*] U01 application must include letters of support from the NIH Clinical Center and from the appropriate NIH Institute, i.e., NCI.; Major changes from the previous FOAs (for X02s and U01s) under this program include: [*] The maximum project period has been changed to “5 years” from “4 years”; [*] Patients must be seen at the NIH Clinical Center; [*] The Clinical Center costs will no longer be charged to the grant, except for the cost of drugs that are the subject of the study (standard-of-care drugs will be free).  Therefore, investigators (applicants) will no longer need to prepare the detailed Clinical Center Budget Template to calculate its costs as had previously been required; [*] A single Institutional Review Board (sIRB) is required for any multi-site study that will use the same protocol to conduct non-exempt human subjects research at more than one domestic site; [*] To further assist investigators, the Clinical Center Office of Regulatory Support can provide consultation on issues related to the regulatory requirements and assistance in protocol navigation and attaining approvals. ; In order to learn more about partnership opportunities at the NIH Clinical Center, please send an e-mail to ClinicalCtrPartner@mail.nih.gov.; I (Minkyung Song at songm@mail.nih.gov) serve as your point of contact at the NCI to discuss preliminary scientific and administrative questions you may have.  We look forward to hearing your interest in this program.; Thank you. Sincerely, [brought to our attention by] Minkyung Song; Minkyung (Min) H. Song, Ph.D.; Program Director; Investigational Drug Branch; Cancer Therapy Evaluation Program; Division of Cancer Treatment and Diagnosis; National Cancer Institute; National Institutes of Health; 9609 Medical Center Drive Room 5-W564, MSC 9739; Rockville, MD 20850; Phone: 240-276-6139; E-mail: songm@mail.nih.gov

 

 

 

[NTW] [IRVING INSTITUTE]
Irving Institute Translational Therapeutics Accelerator (TRx) Pilot RFA

Sponsor: Irving Institute

Deadline(s): 11/15/2018 (Pre-Proposals)

Contact: The pre-proposal will be confidential; however, we suggest you discuss the application and project with your Columbia Technology Ventures licensing officer prior to applying. If you do not have a licensing officer, please reach out to techventures@columbia.edu;

Link(s): http://irvinginstitute.columbia.edu/resources/trx_pilot.html

https://r2eport.files.wordpress.com/2014/04/trx-2019-rfa.pdf

(Translational Therapeutics (TRx) Accelerator: Pilot Award Pre-Proposal Instructions)

https://r2eport.files.wordpress.com/2014/04/l2m-life-sciences_rfa-2018-2019-cycle1.pdf

(Columbia Lab-to_market Accelerators | Life Sciences Call for Applications)

Additional Information: Irving Institute Translational Therapeutics Accelerator (TRx) Pilot RFA - Request for departmental distribution; Hello, I hope this note finds you well. I am happy to announce the third cycle of the Translational Therapeutics (TRx) Accelerator Pilot Award (Link). The TRx program will provide selected projects with funding up to $75,000 as well as mentorship from academic and industry experts in drug development.   The Irving Institute Translational Therapeutics (TRx) Accelerator is a therapeutic development accelerator program that is playing a critical role in translating the outstanding basic science discoveries at Columbia University into commercial therapeutics. We focus on providing funding, education, partnership and mentorship to Columbia Investigators, with a goal of advancing novel therapies from the lab towards clinic. In addition to funding and project specific mentorship, applicants will also receive training through a drug development boot camp with a special focus on the development and commercialization of therapeutics. To date, the TRx has provided funding to 10 full projects, which are progressing towards their goals with the support of a team of industry advisors and Columbia Technology Ventures.; We are seeking translational project proposals and would appreciate your support in disseminating this opportunity within your department.; Two -page pre-proposals are due Thursday, November 15th. Instructions and eligibility guidelines are attached. Program managers from the TRx, Accelerator Cancer Therapeutics (ACT) and BiomedX (prior Coulter device oriented accelerator) programs will be available for questions on the Morningside and CUMC campus in October (information attached).; Thank you for your continued support of Columbia University’s innovations; [brought to our attention by] Akiva Mintz, MD, PhD, MHA; CoDirector, Translational Therapeutics Accelerator (TRx); CoDirector, Pilot and Collaborative Translational and Clinical Studies Resource (PCSR); Columbia University Irving Institute for Clinical and Translational Research; Professor and Vice Chair Translational Research; Director, Columbia University PET Center; Division Chief, Nuclear Medicine; Department of Radiology; Columbia University College of Physicians and Surgeons; Radiology Administrative Office, 1st Floor, Room PH1-333; New York, NY 10032;  Office Phone: 212-305-5521; Email: am4754@cumc.columbia.edu [*]

 

 

[NTW] [IRVING INSTITUTE]

TL1 Training Programs Postdoctoral

Sponsor: Irving Institute

Deadline(s): 12/14/2018 (Priority Deadline, rolling admission thereafter)

Contact: Questions? Contact the Irving Institute Education Center at ctsa_edu@cumc.columbia.edu 

Link(s): http://irvinginstitute.columbia.edu/education/research_train_t32.html      

Additional Information: We are seeking applications from postdoc with professorial appointments for funding to begin July 1st, 2019.  Please note that certain qualifications apply. Anticipated Award Date: July 1, 2019. [*]

 

 

 

[NTW] [IRVING INSTITUTE]

Irving Institute TL1 Training Programs Doctoral

Sponsor: Irving Institute

Deadline(s): 12/14/2018 (Priority Deadline, rolling admission thereafter)

Contact: Questions? Contact the Irving Institute Education Center at ctsa_edu@cumc.columbia.edu 

Link(s): http://irvinginstitute.columbia.edu/education/research_train_t32.html 

Additional Information: We are seeking applications from doctoral students with funding to begin July 1st, 2019. Please note that certain qualifications apply.; Anticipated Award Date: July 1, 2019. [*]

 

 

NTW] [RESEARCH RESOURCES INFORMATION SESSION]
MyGrants, A Secure Analytic Dashboard to Assist PIs in Managing their Research Funded Projects at-a-Glance

Sponsor: Research Resources

Deadline(s): Thursday December 13, 2018 (12/13/2018), 3:30 PM – 5:00 PM; Hess Student Commons

Contact: To RSVP, please email Craig Kandell at ckk7@columbia.edu

Link(s): https://www.mailman.columbia.edu/public-health-now/events/mygrants

Additional Information: Please join the Research Resources Office on Thursday December 13, 2018 (12/13/2018) from 3:30 PM – 5:00 PM in Hess Student Commons for a talk with Dr. Rudi Odeh-Ramadan, Vice President For Research Administration, Columbia University, and Ms. Halayn Hescock, Senior Director, Research Services, Columbia University Information Technology, who will present “MyGrants, A Secure Analytic Dashboard to Assist PIs in Managing their Research Funded Projects at-a-Glance”. Time will be allocated for questions and answers. This event is sponsored by the Mailman School Research Resources (R2) Office. All in the Columbia Community are welcome to attend. To RSVP, please email Craig Kandell at ckk7@columbia.edu

 

 

[NTW] [ASPPH WEEKLY NEWSLETTER]

ASPPH WEEKLY NEWSLETTER, 11/09/18

Sponsorhttp://aspph.org

Deadline(s): NA

Contact: submissions@aspph.org; ASPPH 1900 m Street NW, Suite 710 Washington, DC 20036;

Link(s): http://aspph.cmail19.com/t/ViewEmail/d/F6C960711061ECC62540EF23F30FEDED/772572174F2D0C57C5EC08CADFFC107B

 

 

 

[NTW] [STANDARD DUE DATES]

Standard Due Dates                            

https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm